Cue Health Inc.

HLTHQOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$159

P/E Ratio—

52W High$0.0001

52W Low$0.000001

Avg Volume64K

Open$0.00

Beta0.69

Overview

Cue Health Inc. (HLTHQ) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

HLTHQ · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2024Report Date: May 13, 2024

EPS Actual

-$0.31

Est. -$0.38 · +17.1%

Revenue

$0.01B

Est. $0.01B · -0.5%

Fiscal Period

Q2 FY2024

FY ends December

Report Date

May 13, 2024

After Market Close

▲ Beat EPS✓ 1-Quarter EPS Beat Streak

HLTHQ reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$93.32

Rev. $1001.5B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$93.32

Rev. Est.$1001.5B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 13, 2026	—	—	—	—	—	—
◌ Q3 FY2026	Aug 13, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 12, 2026	-$0.25	—	—	—	$0.03B	—
◌ Q1 FY2025	Feb 11, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Dec 30, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Aug 14, 2024	-$0.36	—	—	—	$0.01B	—
▲ Q2 FY2024	May 13, 2024	-$0.38	-$0.31	+17.1%	$0.01B	$0.01B	-0.5%
▼ Q4 FY2023	Dec 31, 2023	-$0.43	-$0.96	-124.3%	$0.02B	$0.02B	+6.3%

Q3 FY2026

Aug 13, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2026

Aug 13, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 12, 2026

EPS Actual

—

EPS Est.

-$0.25

EPS Surpr.

—

Revenue

—

Q1 FY2025

Feb 11, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 30, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 14, 2024

EPS Actual

—

EPS Est.

-$0.36

EPS Surpr.

—

Revenue

—

Q2 FY2024

May 13, 2024Beat

EPS Actual

-$0.31

EPS Est.

-$0.38

EPS Surpr.

+17.1%

Revenue

$0.01B

Q4 FY2023

Dec 31, 2023Miss

EPS Actual

-$0.96

EPS Est.

-$0.43

EPS Surpr.

-124.3%

Revenue

$0.02B

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2025	$-0.25	$-0.25	$-0.25	1
Q3 FY2025	$-0.26	$-0.26	$-0.26	1
Q2 FY2025	$-0.28	$-0.28	$-0.28	1
Q1 FY2025	$-0.30	$-0.30	$-0.30	1
Q4 FY2024	$-0.17	$-0.17	$-0.17	1
Q3 FY2024	$-0.18	$-0.18	$-0.18	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2025	$0.0B	$0.0B	$0.0B	1
Q3 FY2025	$0.0B	$0.0B	$0.0B	1
Q2 FY2025	$0.0B	$0.0B	$0.0B	1
Q1 FY2025	$0.0B	$0.0B	$0.0B	1
Q4 FY2024	$0.0B	$0.0B	$0.0B	1
Q3 FY2024	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2024	May 13, 2024	+17.1%	$0.13	$0.12	-5.43%
▼ Q4 FY2023	Dec 31, 2023	-124.3%	$0.16	$0.23	+39.88%
▲ Q3 FY2023	Sep 30, 2023	+31.1%	$0.44	$0.41	-6.33%
▼ Q2 FY2023	Jun 30, 2023	-7.6%	$0.39	$0.37	-4.65%
▼ Q1 FY2023	Mar 31, 2023	-2.6%	$1.75	$1.82	+4.00%
▲ Q4 FY2022	Dec 31, 2022	+61.1%	$2.07	$2.13	+2.90%

Q2 FY2024-5.43%

Report Date

May 13, 2024

EPS Beat/Miss

+17.1%

Price Before

$0.13

Price After

$0.12

Q4 FY2023+39.88%

Report Date

Dec 31, 2023

EPS Beat/Miss

-124.3%

Price Before

$0.16

Price After

$0.23

Q3 FY2023-6.33%

Report Date

Sep 30, 2023

EPS Beat/Miss

+31.1%

Price Before

$0.44

Price After

$0.41

Q2 FY2023-4.65%

Report Date

Jun 30, 2023

EPS Beat/Miss

-7.6%

Price Before

$0.39

Price After

$0.37

Q1 FY2023+4.00%

Report Date

Mar 31, 2023

EPS Beat/Miss

-2.6%

Price Before

$1.75

Price After

$1.82

Q4 FY2022+2.90%

Report Date

Dec 31, 2022

EPS Beat/Miss

+61.1%

Price Before

$2.07

Price After

$2.13

Avg Beat Reaction-2.95%

Avg Miss Reaction+13.08%

Beat Rate3 / 6 quarters

Largest Move+39.88% (Q4 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Cue Health Inc. (HLTHQ) most recently reported earnings on May 13, 2024 for Q2 FY2024, posting EPS of $-0.31 — beating the analyst consensus of $-0.38 by +17.1%. The next HLTHQ earnings date is expected around September 1, 2026.

Each quarter, investors track HLTHQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HLTHQ revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

HLTHQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

HLTHQ earnings · 5 questions

Cue Health Inc.'s next earnings report is expected around September 1, 2026. HLTHQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HLTHQ historically reports after market close (AMC).

HLTHQ earnings datewhen is HLTHQ earningsHLTHQ next earnings datewhen does HLTHQ report earningsHLTHQ earnings calendar

▸ Source: FMP · Cue Health Inc. SEC filings · US GAAP · Cue Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026